TC Medical(SH:600763)2025-04-25 11:00Financial Performance - The company's operating revenue for Q1 2025 was CNY 744.61 million, an increase of 5.11% compared to CNY 708.44 million in the same period last year[5]. - Net profit attributable to shareholders was CNY 183.93 million, reflecting a growth of 6.22% from CNY 173.22 million year-on-year[5]. - Basic and diluted earnings per share were both CNY 0.41, representing a 5.13% increase from CNY 0.39 in the same period last year[5]. - Total operating revenue for Q1 2025 reached ¥744,611,704.47, an increase of 5.5% compared to ¥708,442,365.10 in Q1 2024[21]. - Net profit for Q1 2025 was ¥216,103,399.66, representing a 5.9% increase from ¥203,864,140.15 in Q1 2024[21]. - The net profit attributable to shareholders of the parent company was ¥183,925,013.61, compared to ¥173,151,359.78 in the same period last year, reflecting a growth of 6.5%[22]. - Basic and diluted earnings per share for Q1 2025 were both ¥0.41, up from ¥0.39 in Q1 2024[22]. Cash Flow - The net cash flow from operating activities reached CNY 147.69 million, up 13.93% from CNY 129.41 million in the previous year[5]. - The company reported a total cash flow from operating activities of ¥670,695,631.81 for Q1 2025, compared to ¥646,195,492.97 in Q1 2024[24]. - The net cash flow from operating activities was $147,693,433.62, an increase from $129,630,596.75 in the previous period, reflecting a growth of approximately 13.5%[25]. - The total cash inflow from investment activities was $5,273,912.51, down from $8,010,488.89, indicating a decrease of about 34.3%[25]. - The net cash flow from financing activities was -$106,653,416.80, worsening from -$64,356,040.91, representing a decline of approximately 65.5%[26]. - The cash inflow from operating activities totaled $677,575,609.67, compared to $653,342,191.28, reflecting an increase of about 3.7%[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 6.26 billion, a 1.31% increase from CNY 6.18 billion at the end of the previous year[6]. - The company's current assets totaled RMB 935,692,569.16, up from RMB 917,629,396.66 at the end of 2024, indicating an increase of about 1.36%[15]. - The total non-current assets reached RMB 5,327,679,518.15, compared to RMB 5,264,459,245.73 previously, reflecting an increase of approximately 1.2%[16]. - Total liabilities decreased to ¥1,689,279,715.45 in Q1 2025 from ¥1,822,999,066.66 in Q1 2024, indicating a reduction of approximately 7.3%[17]. - The total liabilities include accounts payable of RMB 128,439,580.55, which decreased from RMB 136,650,854.56, indicating a reduction of about 6.5%[16]. - The company reported a decrease in employee compensation payable from RMB 39,474,780.64 to RMB 12,555,784.59, a significant drop of approximately 68.2%[16]. Equity - Shareholders' equity attributable to the parent company was CNY 4.21 billion, up 4.51% from CNY 4.03 billion at the end of the previous year[6]. - Total equity increased to ¥4,574,092,371.85 in Q1 2025 from ¥4,359,089,575.73 in Q1 2024, marking an increase of about 4.9%[17]. - The total equity of the company is not explicitly stated but can be inferred from the total assets and liabilities, indicating a stable financial position[15][16]. Strategic Developments - The company completed the acquisition of 100% equity in Hangzhou Haiyin Technology Co., Ltd. in October 2024, which will be reflected in the financial statements[7]. - The company has not reported any significant changes in shareholder structure or major strategic shifts during the reporting period[14]. Other Financial Metrics - The company reported a significant increase in contract liabilities by 251.35%, primarily due to an increase in advance rental payments[10]. - The net cash flow from investing activities decreased by 57.07%, mainly due to cash payments for the construction of fixed assets and intangible assets[10]. - Cash received from sales of goods and services in Q1 2025 was ¥670,695,631.81, an increase from ¥646,195,492.97 in Q1 2024[24]. - The company's long-term borrowings were reported at ¥169,000,000.00, reflecting a strategic focus on managing debt levels[17]. - Cash outflows for investment activities totaled $69,481,305.03, significantly lower than $157,782,538.09 from the previous period, showing a reduction of approximately 56%[25]. - Cash paid for employee compensation was $316,528,548.52, up from $304,031,478.13, indicating an increase of approximately 4.1%[25]. - The cash outflow for taxes paid was $27,155,619.42, a decrease from $37,916,356.61, representing a reduction of about 28.4%[25]. - The net cash flow from investment activities was -$64,207,392.52, an improvement from -$149,772,049.20, indicating a reduction in losses of approximately 57.1%[25].